# A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01572948** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 27 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** roflumilast
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01572948
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01572948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01572948, "A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01572948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*